We are live on ! Find out more
COGT icon

Cogent Biosciences
COGT

305 hedge funds and large institutions have $7.17B invested in Cogent Biosciences in 2026 Q1 according to their latest regulatory filings, with 80 funds opening new positions, 116 increasing their positions, 82 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

122% more first-time investments, than exits

New positions opened: 80 | Existing positions closed: 36

41% more repeat investments, than reductions

Existing positions increased: 116 | Existing positions reduced: 82

34% more call options, than puts

Call options by funds: $36.3M | Put options by funds: $27M

16% more capital invested

Capital invested by funds: $6.18B → $7.17B (+$986M)

14% more funds holding

Funds holding: 267 → 305 (+38)

7.47% less ownership

Funds ownership: 122.27% → 114.8% (-7.5%)

12% less funds holding in top 10

Funds holding in top 10: 25 → 22 (-3)

Holders
305
Holders Change
+38
Holders Change %
+14.23%
% of All Funds
3.75%
Holding in Top 10
22
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-12%
% of All Funds
0.27%
New
80
Increased
116
Reduced
82
Closed
36
Calls
$36.3M
Puts
$27M
Net Calls
+$9.21M
Net Calls Change
+$3.98M

Top Buyers

1
BlackRock
BlackRock
New York
+$113M
2
Goldman Sachs
Goldman Sachs
New York
+$101M
3
Invesco
Invesco
Georgia
+$68.1M
4
Pictet Asset Management
Pictet Asset Management
Switzerland
+$62.3M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$52.7M

Top Sellers

1
FFM
Fairmount Funds Management
Pennsylvania
-$129M
2
RI
RTW Investments
New York
-$78.8M
3
DFO
Duquesne Family Office
New York
-$78.7M
4
KCM
Kynam Capital Management
New Jersey
-$78.6M
5
VC
Vivo Capital
California
-$73M
Name Holding Trade Value Shares
Change 		Change in
Stake
CM
151
Castleark Management
Illinois
$2.46M +$2.36M +63,950 New
Envestnet Asset Management
152
Envestnet Asset Management
Illinois
$2.4M +$1.72M +46,635 +299%
PA
153
Profund Advisors
Maryland
$2.2M +$528K +14,302 +33%
Royal Bank of Canada
154
Royal Bank of Canada
Ontario, Canada
$2.17M +$1.45M +39,403 +234%
JFG
155
Jefferies Financial Group
New York
$2.14M -$721K -19,538 -26%
LP
156
LMR Partners
United Kingdom
$2.13M +$35.3K +956 +2%
Two Sigma Investments
157
Two Sigma Investments
New York
$2.04M +$1.5M +40,490 +321%
TD Asset Management
158
TD Asset Management
Ontario, Canada
$2.02M -$139K -3,752 -7%
GGHC
159
Gilder Gagnon Howe & Co
New York
$2.01M -$41.1K -1,112 -2%
ACM
160
AIHC Capital Management
$1.98M -$1.79M -48,598 -49%
HIS
161
Harvest Investment Services
Illinois
$1.96M +$744K +20,151 +66%
XT
162
XTX Topco
Cayman Islands
$1.94M +$1.86M +50,470 New
Adage Capital Partners
163
Adage Capital Partners
Massachusetts
$1.92M -$1.85M -50,000 -50%
Schroder Investment Management Group
164
Schroder Investment Management Group
United Kingdom
$1.89M – – –
Universal-Beteiligungs- und Servicegesellschaft
165
Universal-Beteiligungs- und Servicegesellschaft
Germany
$1.74M +$1.32M +35,665 +373%
IIM
166
INTECH Investment Management
Florida
$1.63M -$711K -19,260 -31%
EGM
167
Engineers Gate Manager
New York
$1.62M +$577K +15,623 +59%
N
168
Natixis
France
$1.6M +$1.53M +41,536 New
KOCAA
169
Knights of Columbus Asset Advisors
Connecticut
$1.5M +$1.44M +39,039 New
PFSRSONJ
170
Police & Firemen's Retirement System of New Jersey
New Jersey
$1.49M +$49.3K +1,336 +4%
GC
171
Guggenheim Capital
Illinois
$1.49M +$1.43M +38,755 New
Bank of Montreal
172
Bank of Montreal
Ontario, Canada
$1.47M +$1.05M +28,417 +287%
TRSOTSOK
173
Teachers Retirement System of the State of Kentucky
Kentucky
$1.44M – – –
SG Americas Securities
174
SG Americas Securities
New York
$1.41M -$40.9K -1,107 -3%
TC
175
TwinBeech Capital
New York
$1.38M +$244K +6,600 +23%
5 6
7
8 9

COGT Hedge Fund Activity: Q1 2026 in Review

305 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Cogent Biosciences (COGT) for Q1 2026, worth a combined $7.17B — up 16% from $6.18B a quarter earlier.

Buyers outnumbered sellers: 80 funds opened new COGT positions and 36 closed out — a net gain of 44 holders — while 116 added to existing stakes and 82 trimmed.

The largest buyer was BlackRock, adding an estimated $113M. The largest seller was Fairmount Funds Management, cutting an estimated $129M.

  • 305 institutional investors held Cogent Biosciences (COGT) as of Q1 2026, up from 267 in Q4 2025.
  • Funds reported $7.17B of Cogent Biosciences stock for Q1 2026, up 16% quarter-over-quarter.
  • 80 funds opened new Cogent Biosciences positions in Q1 2026 and 36 closed out, a net change of +44 holders.
  • The largest Cogent Biosciences buyer in Q1 2026 was BlackRock, an estimated $113M added.
  • The largest Cogent Biosciences seller in Q1 2026 was Fairmount Funds Management, an estimated $129M sold.

Based on aggregated 13F filings for Q1 2026.